Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Galena Biopharma In (GALE)

0.3327 -0.0172 (-4.9157%)

8/23/2017  3:13pm

Open:

0.3472

Pre. Close:

0.3499

High:

0.3541

Low:

0.3300

Volume:

310,752

Market Cap:

12.78M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.35 - 0.36

0.36 - 0.37

Low:

0.31 - 0.32

0.32 - 0.33

Close:

0.33 - 0.35

0.35 - 0.37

Technical analysis  (as of: 2017-08-23 2:32:39 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 0.54     One year: 0.69

Support:

Support1: 0.26    Support2: 0.22

Resistance:

Resistance1: 0.46    Resistance2: 0.59

Pivot:

0.40

Moving Averages:

MA(5): 0.34     MA(20): 0.44

MA(100): 0.55     MA(250): 0.92

MACD:

MACD(12,26): -0.06     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 24.72     %D(3): 24.54

RSI:

RSI(14): 26.79

52-Week:

High: 9.1040  Low: 0.2568  Change(%): -18.3

Average Vol(K):

3-Month: 57171  10-Days 22548

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GALE has closed above bottom band by 31.8%. Bollinger Bands are 217.2% wider than normal. The large width of the bands suggest high volatility as compared to GALE's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

Fri, 11 Aug 2017 18:00:00 GMT
Galena Biopharma (GALE) Discusses Galena Biopharma and SELLAS Life Sciences ...

Wed, 23 Nov 2016 21:33:45 GMT
Galena Biopharma, Inc. in 3 Charts

Mon, 14 Aug 2017 17:48:45 GMT
Earnings Reaction History: Galena Biopharma, Inc., 80.0% Follow-Through ...

Wed, 12 Jul 2017 10:30:00 GMT
Galena Biopharma Provides Corporate Update

Tue, 22 Aug 2017 21:30:06 GMT
Galena Biopharma Inc. (GALE) Soars 7.66% on August 22

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

37.44

Shares Float (M)

24.49

% Held by Insiders

% Held by Institutions

Shares Short (K)

4610

Shares Short Prior Month (K)

4560

Stock Financials

EPS

-1.310

EPS Est. Current Year

-0.710

EPS Est. Next Year

-1.390

EPS Est. Next Quarter

-0.190

Forward EPS

-0.858

Book Value (p.s.)

0.730

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-25.6

Return on Equity (ttm)

-1.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.743

Qtrly Earnings Growth

Operating Cash Flow (M)

-42.10

Levered Free Cash Flow (M)

-37.89

FoxReading.com

Valuation

P/E

-0.26

P/E Growth Ratio

-0.04

P/BV

0.46

P/S

P/CF

-0.30

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-11-14

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.